Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Millennium welcomes new member to Board of Directors

Millennium welcomes new member to Board of Directors

5th October 2007

Millennium Pharmaceuticals has announced the election of Jeffrey M Leiden to its Board of Directors.

Dr Leiden has an extensive experience of the biomedical and pharmaceutical sectors, previously holding the position as president and chief operating officer of the global pharmaceutical business of Abbott Laboratories.

Currently the managing director of life sciences venture capital firm Clarus Ventures, Dr Leiden joins the board as an independent director.

Deborah Dunsire, president and chief executive officer at Millennium expressed her delight in welcoming Dr Leiden to the Millennium Board of Directors.

“We believe his diverse pharmaceutical and scientific experience will enable him to help guide our continued growth and success in our mission of delivering vital medicines to patients,” she said.

Dr Leiden also has a distinguished career in the academic field, serving as professor of medicine and pathology and chief of cardiology at the University of Chicago.

Dr Leiden stated his pleasure in taking up the post, insisting that he would utilise his knowledge and experience to further the company’s success.

Founded in 1993, Millennium Pharmaceuticals is a leading biotechnology company which currently markets the oncology drug Velcade.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.